Podcasts about Infection

Share on
Share on Facebook
Share on Twitter
Share on Reddit
Copy link to clipboard

Invasion of an organism's body tissues by disease-causing agents

  • 2,994PODCASTS
  • 6,214EPISODES
  • 38mAVG DURATION
  • 3DAILY NEW EPISODES
  • Oct 17, 2021LATEST
Infection

POPULARITY

20112012201320142015201620172018201920202021


Best podcasts about Infection

Show all podcasts related to infection

Latest podcast episodes about Infection

YUTORAH: R' Dr. Aaron Rakeffet-Rothkoff -- Recent Shiurim
Rav Menashe Klein: The U.S. Postage Stamp and the German Coins with God's Name on Them. Rav Moshe Feinstein and the Hospital that Requires Tefillin be Burned in Order to Prevent Infections From Spreading Outside the Hospital

YUTORAH: R' Dr. Aaron Rakeffet-Rothkoff -- Recent Shiurim

Play Episode Listen Later Oct 17, 2021 119:32


AP Audio Stories
Bill Clinton recovering from urological infection, aide says

AP Audio Stories

Play Episode Listen Later Oct 15, 2021 1:26


1010 WINS ALL LOCAL
Former President Clinton is in the hospital this morning being treated for an infection. A 14 year old boy was getting on a bus in Harlem when somebody opened fire on him. Cops think this might have been gang related. Teachers who oppose the City's vacci

1010 WINS ALL LOCAL

Play Episode Listen Later Oct 15, 2021 6:44


All Local Morning for 10/15/21 See omnystudio.com/listener for privacy information.

Dutch News
The Sinterklaas Mortal Kombat Edition - Week 41 - 2021

Dutch News

Play Episode Listen Later Oct 15, 2021 58:06


Sinterklaas ophef comes round earlier every year, but there's a twist this time around: it's not about Zwarte Piet. A critical review of the government's coronavirus strategy comes out just as cases soar again and ministers promise to repeat the same mistakes as last year. Infections are certainly moving much faster than efforts to compensate for the victims of the child benefit scandal, with MPs, judges, the ombudsman and the Council of Europe all criticising the handling of the affair. And Rotterdam moves another 40 centimetres away from sea level as the new highest building in the Netherlands tops out.

AP Audio Stories
Bill Clinton in hospital for non-COVID-related infection

AP Audio Stories

Play Episode Listen Later Oct 15, 2021 1:33


Infection - The SURVIVAL PODCAST
Twitch Hack – Infection – The SURVIVAL PODCAST Episode 352

Infection - The SURVIVAL PODCAST

Play Episode Listen Later Oct 14, 2021 65:49


Massive Twitch Hack, Brian plays New World, China and more on this week's episode of Infection – The SURVIVAL PODCAST The post Twitch Hack – Infection – The SURVIVAL PODCAST Episode 352 appeared first on Infection - The SURVIVAL PODCAST.

What Do The Gays Think?
My Covid-19 Breakthrough Infection Experience

What Do The Gays Think?

Play Episode Listen Later Oct 13, 2021 56:43


Matt was out sick for a few weeks with a breakthrough case of Covid-19. In this episode, Matt describes his experience with his breakthrough case. In addition, the gays also discuss some other recent events that we've missed, such as the California recall election, Nicki Minaj's "Trinidad" cousin's friend, and the $3.5 trillion reconciliation package stuck in Congress.Follow us on Twitter! https://twitter.com/WDTGTPodcastFollow us on Twitch! https://www.twitch.tv/whatdothegaymersthinkLogo Credit: Jackie Vandewater | vandewater.studio | @jakquillime | twitch.tv/jackie_the_bananasCheck out our merch!! https://www.redbubble.com/shop/ap/88055567

KPFA - The Pacifica Evening News, Weekdays
California joins historic lawsuit against ghost gun manufacturers; World Health Organization report: climate change biggest threat to human health; COVID-19 infections down 12%, deaths down 5% in U.S.

KPFA - The Pacifica Evening News, Weekdays

Play Episode Listen Later Oct 13, 2021 59:58


REBEL Cast
REBEL Core Cast 66.0 – Congenital Cardiac Issues

REBEL Cast

Play Episode Listen Later Oct 13, 2021 27:51


Take Home Points Once you figure out the neonate that presented to your ED is sick, run through a differential of why then can be sick so you don't anchor. I like to use TIMOT (Trauma, Infection, Metabolic, Organs, Tox) but use whatever works for you. Use your detailed history looking for risk factors to ... Read more The post REBEL Core Cast 66.0 – Congenital Cardiac Issues appeared first on REBEL EM - Emergency Medicine Blog.

The Orthobullets Podcast
Recon | Prosthetic Joint Infection

The Orthobullets Podcast

Play Episode Listen Later Oct 13, 2021 29:33


In this episode, we review the high-yield topic of Prosthetic Joint Infection from the Recon section. Follow Orthobullets on Social Media: Facebook: www.facebook.com/orthobullets Instagram: www.instagram.com/orthobulletsofficial Twitter: www.twitter.com/orthobullets LinkedIn: www.linkedin.com/company/27125689 YouTube: www.youtube.com/channel/UCMZSlD9OhkFG2t25oM14FvQ --- Send in a voice message: https://anchor.fm/orthobullets/message

VPR News Podcast
Reporter debrief: COVID case counts climb after dip last week. Infection rates highest among kids under 10

VPR News Podcast

Play Episode Listen Later Oct 12, 2021 4:33


At Gov. Phil Scott's COVID briefing on Tuesday, Oct. 12, officials said case counts over the past seven days rose to some of the highest levels since the beginning of the pandemic, and infection rates are most severe among young children who aren't yet eligible for the vaccine.

Today with Claire Byrne
Rising infection numbers

Today with Claire Byrne

Play Episode Listen Later Oct 12, 2021 15:57


Niamh O'Beirne, National Lead Testing and Tracing, on rising infection numbers

Fearless Health Podcast
Is C. Diff Infection Affecting Your Gut Health? - with Dr. Sahil Khanna | Ep. 24

Fearless Health Podcast

Play Episode Listen Later Oct 8, 2021 54:28


Are you struggling with a C. Diff Infection? Often referred to as C. difficile or C. diff, Clostridioides difficile is a bacterium that can infect your large intestine. It is the most common bacterial infection in hospitals, and in America, between 450,000 to 500,000 people get C. Diff infections every year! In today's episode, we are discussing the signs and symptoms of C. Diff, who can be affected by C. Diff infection, helpful probiotics, and more!- We answer these questions:- What signs and symptoms should you be looking out for?- How does C. Diff affect patients of different ages?- Is C. Diff Infection related to Inflammatory Bowel Disease?- How and where can you contract C. Diff?- What is megacolon?- Does the health of your microbiome affect your odds of infection?- What probiotics can help?- And more!-Connect with Dr. Sahil Khanna:Mayo Clinic: https://www.mayoclinic.org/biographies/khanna-sahil-m-b-b-s-m-s/bio-20097159Twitter :https://twitter.com/khanna_s?lang=en -Schedule a consultation with Alexis:www.altfammed.comSupplementsBinding Fiber Support Capsules - https://drannmariebarter.com/product/binding-fiber-support-capsules/ Binding Fiber Support Powder - https://drannmariebarter.com/product/binding-fiber-support-powder/ - About Dr. Khanna:Dr. Sahil Khanna is a Professor of Medicine in the Division of Gastroenterology and Hepatology at Mayo Clinic, Rochester, MN. He completed Medical School at the All India Institute of Medical Sciences, New Delhi; followed by Post Doctoral Research at University of California San Diego, CA; residency in Internal Medicine and Fellowship in Gastroenterology and Hepatology at Mayo Clinic, Rochester, MN before joining the Faculty. He also completed Masters in Clinical and Translational Sciences during his fellowship. He is directing the Comprehensive Gastroenterology Interest group, C. difficile Clinic, Fecal Microbiota Transplantation program and C. difficile related Clinical Trials at Mayo Clinic, Rochester, MN. He has over 120 publications, serves as reviewer on the editorial board of several journals, and has won numerous awards. -Subscribe for more gut health content and share this podcast with a friend! Take a screenshot of this episode and tag Dr. Ann-Marie Barter:http://instagram.com/drannmariebarter-Dr. Ann-Marie Barter is a Functional Medicine and Chiropractic Doctor at Alternative Family Medicine & Chiropractic. She is the clinic founder of Alternative Family Medicine & Chiropractic that has two offices: one in Longmont and one in Denver. They treat an array of health conditions overlooked or under-treated by conventional medicine, called the "grey zone". https://altfammed.com/https://drannmariebarter.com/

Spectrum | Deutsche Welle
When do side effects happen from COVID-19 vaccines?

Spectrum | Deutsche Welle

Play Episode Listen Later Oct 7, 2021 8:40


Side effects from COVID-19 vaccines are really, really rare. But, if you're one of the unlucky ones, when would you find out? Also, the "supermarket question" has now been answered, and a few dozen mice had BioNTech-Pfizer injected right into their tails — and may have helped solve the heart inflammation mystery.

The Derm Vet Podcast
84. Douxo® S3 and Ophytrium: advancing ingredients to improve epidermal barrier

The Derm Vet Podcast

Play Episode Listen Later Oct 7, 2021 50:34


Initially, I was a little thrown off when I heard Douxo® was changing their main active ingredient from phytosphingosine to ophytrium. Why change it now? But, as I learned more about the upgrades that were being made to the new Douxo® S3 line, I was really excited hear about the thought and innovation that went into upgrading this line.On this episode of the podcast, I got to talk to two amazing ladies from Ceva Animal Health: Dr. Christine Mullins (veterinary services manager) and Jacqueline Hodges (associate key account manager). They walk though the steps to this upgrade to assessing its effect on new canine skin models, a human skin model (to assure safety for owners) and in real canine patients. Not only were the ingredients considered but the user experience with the bottle, smell and lather. Enjoy learning all about this new line of topicals!

The Newsmax Daily with Rob Carson
The Higher The Vaccine Rate, The Higher The Infection Rate (10/6/21)

The Newsmax Daily with Rob Carson

Play Episode Listen Later Oct 6, 2021 40:43


- The Idiotic Democrat-backed “American Rescue Plan” will kill our economy as shown by thousands of angry Americans greeting Joe Biden yesterday in Michigan  - A new study out of Harvard suggests that it is indeed the Biden Administration that is spreading misinformation about COVID - Phony Facebook whistleblower Frances Haugen does the obvious, increasing government's ability to spy on YOU Learn more about your ad choices. Visit megaphone.fm/adchoices

Women On Top
Data and risk analyst Dr. Nini Munoz talks why breakthrough infections happen, will the vaccine affect your fertility, and are kids really at risk?

Women On Top

Play Episode Listen Later Oct 6, 2021 75:14


Data and risk analyst Dr. Nini Munoz talks why breakthrough infections happen, will the vaccine affect your fertility, and are kids really at risk?See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

UF Health Podcasts
Fasting may help fight infections, study suggests

UF Health Podcasts

Play Episode Listen Later Oct 6, 2021


Intermittent fasting is all the rage. The diet, which restricts eating to certain hours,…

UF Health Podcasts
Fasting may help fight infections, study suggests

UF Health Podcasts

Play Episode Listen Later Oct 6, 2021


Intermittent fasting is all the rage. The diet, which restricts eating to certain hours,…

Liberty Roundtable Podcast
Radio Show Hour 1 – 10/05/2021

Liberty Roundtable Podcast

Play Episode Listen Later Oct 5, 2021 54:49


* The Great Barrington Declaration - Focused Protection? * Joe Biden granted Congress an exemption from COVID shots, while his Department of Defense ordered every active and reserve service member to get the shots. * Fauci declares Americans should 'give up' individual freedom 'for the greater good of society'. * Antibodies Persist for More Than a Year After COVID-19 Infection, Study Finds - Ivan Pentchoukov. * Vaccine Antibodies Decline 7 Months After Second Shot: US Study! * Protesters at hospitals! * Second Hour BrightEON.tv Guest: Houston County, TX Sheriff Randy Hargrove * Rand Paul Lays Into HHS Sec. Becerra for Failing to Acknowledge COVID Natural Immunity. * School Boards Ask Biden Admin to Treat Parents' Protests as ‘Domestic Terrorism'. * Dr. Fauci: 'Migrants Coming Over the Border - That's Not How You Get Diseases Into the Country'. * COVID-19 Detention Camps: Are Government Round-Ups of Resistors in Our Future? - John and Nisha Whitehead. * We all need to nullify the Vaccine Mandate! * United States Could Lose Its AAA Credit Rating, Fitch Warns. * Second Hour Tuesday TV Archives are available on BrightEON.tv.

Question of the Week - From the Naked Scientists
Why do we keep catching the same diseases?

Question of the Week - From the Naked Scientists

Play Episode Listen Later Oct 5, 2021 3:20


This week, listener Rick emailed us to ask "Why do we acquire lifelong immunity against some pathogens but not others?" Sally Le Page asked author and infectious disease researcher at Imperial College, London, John Tregoning, to jog our memories... Like this podcast? Please help us by supporting the Naked Scientists

The Bob Harden Show
Coronavirus Vaccines and "Breakthrough" Infections

The Bob Harden Show

Play Episode Listen Later Oct 1, 2021 59:55


Thank you so much for listening to the Bob Harden Show, celebrating over ten years broadcasting weekdays on the internet – providing you news and commentary rooted in the principles of individual liberty, personal responsibility, limited government and the rule of law. On Friday's show, we visit with William Yeatman, Research Fellow with the Cato Institute, about the pending government shutdown, the debt ceiling, and the disarray in Congress over Democrat spending bills. We visit with the Director of Health Studies at the Cato Institute, Michael Cannon, about Coronavirus vaccines and “breakthrough” infections. We visit with Marina Berkovich, the Founder and CEO of the Jewish Historical Society of Southwest Florida, about their mission and their partnership with the Holocaust Museum. We also visit with the Founder & CEO of Executive Management Services and author of “The Devil at Our Doorstep,” Dave Bego about union strategies under the Biden administration. Please join us for Monday's show. We have terrific guests including the Founder and Publisher of HistoryCentral.com, Marc Schulman, the President Emeritus of the Foundation for Economic Education, Larry Reed, and Sal Nuzzo from the James Madison Institute. Please join us live at 7 a.m. on this website, or you can access the show anytime on podcast platforms (iTunes, TuneIn, Spotify, and Stitcher, Vurbl,and ChoiceSocial).

The BMJ Podcast
Talk Evidence - testing for respiratory tract infections, cannabis for pain, & covid outcomes

The BMJ Podcast

Play Episode Listen Later Sep 29, 2021 29:13


This week our regular panelists, Helen Macdonald and Joe Ross, are joined by Juan Franco, editor in chief of BMJ Evidence Based Medicine - to take a primary care focussed look at what's been happening in the world of evidence. On this week's episode. As kids go back to school, winter bugs surge and pressure mounts on health services we look at two trials which aimed to use reduce antibiotic prescribing for respiratory tract infections in nursing homes and primary care Juan brings us an update on prescribing medicinal cannabis for pain, based on a recent BMJ rapid recommendation article and linked systematic review and meta-analysis And finally, in covid news, how likely are you to be admitted or die from covid after one or two SARS-CoV 2 vaccinations? Reading list Effect of C reactive protein point-of-care testing on antibiotic prescribing for lower respiratory tract infections in nursing home residents - https://www.bmj.com/content/374/bmj.n2198 Procalcitonin and lung ultrasonography point-of-care testing to determine antibiotic prescription in patients with lower respiratory tract infection in primary care - https://www.bmj.com/content/374/bmj.n2132 Medical cannabis or cannabinoids for chronic pain - https://www.bmj.com/content/374/bmj.n2040 Risk prediction of covid-19 related death and hospital admission in adults after covid-19 vaccination - https://www.bmj.com/content/374/bmj.n2244

Standing Stone Kennels - You Ask We Answer
Foreign Body Infections plus MedKit Giveaway! YAWA Episode 71

Standing Stone Kennels - You Ask We Answer

Play Episode Listen Later Sep 29, 2021 106:13


Subscribe to our YouTube channel here: http://bit.ly/2Dyy9DW Welcome to Standing Stone Kennels - You Ask We Answer (YAWA)! We are back this week with the September Live YAWA Episode 71 (Monthly Giveaway - Standing Stone MED KIT)! We have lots to catch up on as we approach hunting season, and we want to answer your questions! Looking forward to sipping on some drinks and catching up! Send Us Mail Ethan and Kat Pippitt Attn: SSK YOUTUBE 5919 W Pleasant Valley Rd Pretty Prairie, KS 67570 Links Join our Patreon Community - https://bit.ly/SSK-Patreon Our Store - https://bit.ly/SSK-Store Recommended Dog Training Items - https://bit.ly/SSK-recommended-items Video Gear A7Riv Camera - https://amzn.to/2Y6STtH Lens 24-105 f4 - https://amzn.to/3cFXUPg Lens 70-200 f2.8 - https://amzn.to/3cC5NoD Lens 2x adapter - https://amzn.to/3794qN2 Drone - https://amzn.to/2XEK6QP GoPro - https://amzn.to/2z9RM45 Tripod - https://amzn.to/3cBwCJH Lights - https://amzn.to/3eWpj0H Zoom Lapel Recorder - https://amzn.to/2AJFHDa Rode RODECaster Pro - https://bit.ly/SSK-RODECaster Social Media Facebook: www.facebook.com/StandingStoneKennels Instagram: www.instagram.com/standingstonekennels/ Website: www.standingstonekennels.com Ethan and Kat Pippitt are the proud owners of Standing Stone Kennels. They breed German Shorthaired pointers and train all types of dogs for the hunt and the home. Their training strategies are easy to follow and are flexible to meet the needs of individual dogs. They are avid outdoorsmen and when they aren't training dogs they spend their free time hunting all kinds of game across the United States. Produced by: Red 11 Media - red11media.com --- Support this podcast: https://anchor.fm/standingstonekennels-yawa/support

3:12 - The HRP Podcast
COVID Testing Revisited

3:12 - The HRP Podcast

Play Episode Listen Later Sep 29, 2021 47:14


Garfield Drummond, Managing partner at Phoenix Global Health, joins HRP's Shaun Malin and Tom Simmons to talk about the latest developments in at Home COVID Testing Kits. Don't forget to stick around till the end of the pod for the Play Hard section.Make sure you subscribe, give us a review & check us out on social media!YouTubeLinkedInInstagramTwitterFacebookWebsite

Art of Eating
Our Favorite Immune System Boosters! (Ep. 119)

Art of Eating

Play Episode Listen Later Sep 28, 2021 73:48


The immune system has been all the rage over the past year and half!  So we figured not would be a good time to do a bit of a deep dive!  Today we're going to cover who the major players are in the immune system.  Then, we're going to give you some of our favorite immune system-boosting foods, nutrients, and other actionable steps you can take to keep your immune system in tip-top shape! Don't forget!  Get 40% your first order of Life Boost Coffee by using promo code “AOE40” at lifeboostcoffee.com at checkout! Use this link to streamline the process: https://lifeboostcoffee.com/pages/healthy-coffee-ot2e-jhopkins?oid=1&affid=49Experience the lasting joy of cooking with Xtrema® 100% Pure Ceramic Cookware. Xtrema® redefines the cooking process by combining unparalleled versatility with the peace of mind, knowing that every piece of cookware will never leach chemicals, metal, cadmium, lead, or change the taste of your food.  Get 10% off Xtrema cookware using our code ARTOFEATING at checkout!With Culiraw, guilt-free desserts are possible!  They are made of natural organic ingredients that provide your body with fiber, minerals, vitamins and enzymes, sweetened with dates and agave only.  Use code is “aoepodcast” for 10% discount at checkout!Subscribe to Dr. Esposito's YouTube Channel: https://www.youtube.com/channel/UCHRpZFrFsbJIk5fbNIkj4pQ?sub_confirmation=1 Sign up for our newsletter at evokhealth.com and get our 14 Kick-start Recipes & Kitchen Secrets! Feel free to reach out to us at artofeatingpodcast@gmail.com.  You can also follow us on Instagram @artofeatingpodcast.   To reach your hosts, you can find Dr. Esposito at:Email: drvincentesposito@gmail.comIG: @drvincentespositoTikTok: @drvincentesposito Web: insideouthealthwellness.com You can find Dr. Kali at:Web: drkali.com   IG: @dr.kalind 

What The Hal?
119: COVID update, breakthrough infections, refugee health assistance

What The Hal?

Play Episode Listen Later Sep 26, 2021 22:51


Hal is joined by Dr. Matt Waxman to talk about the latest news about the length of protection offered by the Pfizer versus the Moderna vaccine.

FOAMcast -  Emergency Medicine Core Content
COVID-19 Delta Variant and Vaccine Breakthrough Infections

FOAMcast - Emergency Medicine Core Content

Play Episode Listen Later Sep 24, 2021 11:08


In this episode, Jeremy discusses what we know about breakthrough infections in the delta variant era and what this may mean for COVID-19 vaccine boosters. Jeremy's takes can be found at Inside Medicine Show notes/references: FOAMcast.org Thanks for listening! Lauren Westafer and Jeremy Faust

Wine Cellar Media
Republicans Don't Care About Children PLUS Fox17 Checks Pastor Greg Locke

Wine Cellar Media

Play Episode Listen Later Sep 24, 2021 50:00


Fox News Covid denier and snake oil salesperson Laura Ingraham squawked that more kids died from the flu than during Covid, so it's no big deal. Is COVID over now? I didn't get the memo. "Only 555 kids have died from the entire pandemic," Ingraham said. Which is less than the flu killed. Ingraham used the age group of 0-17 to further bash Dr. Fauci. COVID isn't the problem now, it's Dr. Fauci. Ingraham claims CDC figures say "during the last two flu seasons," 911 children and teenagers under 18 died of the flu. By comparison, only 555 have died from COVID throughout the entire pandemic. Laura Ingraham is telling Fox News viewers to not protect their babies, children, and young adults because of Dr. Fauci. That's crazy. And absolutely cruel to the parents and grandparents of children who have died of either the flu OR Covid. Come on, Laura. At some point, you have to have reached bottom. The initial phase of COVID wasn't as infectious or deadly to our children and young adults, but the Delta variant is wreaking havoc on our younger population. Infections among our youth has risen exponentially as well as the death rates. Twitter responded, "So it's 555 dead kids near the end of September. Near the end of July it was 358. That means that August and September saw 200 kids die of covid. That's 3 dead kids a day. The previous 16 months the average was less than one a day. Seems bad?

The Derm Vet Podcast
82. Review of the Clinical Consensus Guidelines for Dermatophytosis

The Derm Vet Podcast

Play Episode Listen Later Sep 23, 2021 10:45


Dermatophytosis can be a frustrating disease process. There are many different diagnostic tests and treatment options. This episode reviews "Diagnosis and treatment of dermatophytosis in dogs and cats: clinical consensus guidelines of the World Association for Veterinary Dermatology". This was an extensive review of the literature over several years. The article is available at: https://pubmed.ncbi.nlm.nih.gov/28516493/

Lillian McDermott
Jacob Teitelbaum, Persistent COVID Symptoms & Solutions

Lillian McDermott

Play Episode Listen Later Sep 22, 2021 59:07


I have heard many share that the people who have persistent COVID have the symptoms of fibromyalgia. Immediately, we contacted Jacob Teitelbaum, MD. Dr. Teitelbaum is a board-certified internist and nationally known expert in the fields of chronic fatigue syndrome, fibromyalgia, sleep, and pain. Dr. Teitelbaum will share how Sleep, Hormones, Infections, Nutrition and Exercise (or the […] The post Jacob Teitelbaum, Persistent COVID Symptoms & Solutions appeared first on LillianMcDermott.com.

The Get Foxy Show
The Rogue Method™ – Tyler Lewis

The Get Foxy Show

Play Episode Listen Later Sep 21, 2021 45:30


The Rogue Method™ alleviates The Big 4 – Toxins, Traumas, Nutritional Deficiencies, and Infections.  By studying the healing patterns of 1000+ patients in clinical practice, Tyler created The Rogue Method™ as a new model of care for patients to achieve better healing outcomes and regain true wellness. This method is now being adopted by integrative […] The post The Rogue Method™ – Tyler Lewis appeared first on The Get Foxy Show.

biobalancehealth's podcast
Healthcast 564 - What can a person do to increase their chances of being protected by an immunization?

biobalancehealth's podcast

Play Episode Listen Later Sep 21, 2021 19:53


See all the Healthcasts at https://www.biobalancehealth.com/healthcast-blog/ Two weeks ago we talked about how a vaccination works in your body to create immunity to a virus. Last week we discussed the issues that put people at risk for getting a virus and for not responding to a vaccine.  The third and last section of our series on viruses and vaccines centers on how to boost your immune system so that you are less likely to get a virus, to die from a virus, and more likely to get immunity from a vaccine. There is a great controversy about vaccines right now, but vaccines have changed the modern world from one where we had a very high death rate from communicable diseases and high childhood death rate to one that is generally protected against communicable viruses, where we now only worry about dying from the diseases of old age.  Most vaccines are given a few times in our lives, like MMR (measles mumps and rubella vaccines), usually when we are children and then every 10 years or so, we get a booster.  The flu vaccine is different, and we get a different vaccine every year that is created to kill the permutation of the flu virus we think is going to go around the world this winter.  Doctors recommend those patients who are not allergic to the flu vaccine to get an immunization against the flu every year, because it is a preventable deadly disease, however we rarely tell our patients how to make their vaccine more effective to provide protection (to decrease the likelihood of immunization failure). The necessary elements for a human being to be adequately protected from a virus and by an immunization include: A healthy immune system with adequate numbers of white blood cells of healthy white blood cells. Good Nutrition A normal blood sugar --intake of a lot of sugar containing food and drinks and carbohydrates, or the presence of uncontrolled Diabetes decreases the ability of a person's immune system to function. Viruses LOVE sugar! Young healthy levels of Testosterone. Testosterone stimulates white blood cell production and modulates the activity of the thymus. Testosterone decreases and becomes deficient as we age, and the activity and effectiveness of the immune system parallels the drop of our testosterone levels in both sexes. Daily moderate exercise. Sitting all day slows your immune response and can accelerate the drop in hormones and the number of white blood cells. To stay healthy, you must exercise every day. Control of stress. High stress, and major negative life events (like divorce, loss of family members, money worries, etc.) can cause your hormone, Cortisol from your adrenal gland, to increase over long periods of time. This blunts the effect of White blood cells and decreases your immune function. Taking action to decrease stress with biofeedback, exercise, prayer, or socializing is important to keep your immune function healthy. You can also take a supplement called Endodren Supplement (1 every am) to keep Cortisol from spiking. Good Gut bacteria—feed the gut biome with  probiotics and good basic nutrition including raw veggies and fruit. Your immunity starts in your gut. Replace declining hormones-- Estradiol, testosterone, and thyroid hormones. At BioBalance Health our patients who have been taking T pellets for over a year had a better immune response to viral infections during 2020 and 2021 and their T cells and B cells reacted more aggressively to kill viruses. In addition to the recommendations above we suggest supplementation to your basic nutrition to improve your immune system: Vitamin D 5,000 IU per day is a must and has been proven to lessen the effects of viruses and improve the response to immunizations. Vitamin C 1000 mg/day Zinc 30 mg po q day Quercetin 250 mg/day My doctor-daughter primes my grand-daughter before her immunizations with a form of liquid vitamin C each day for 3 days and the day of her immunization at the pediatrician's office. This improves her chances of obtaining immunity from that one shot. Special Cases require special immunizations and sometimes boosters: There are some diseases and conditions that require additional treatment and prevention for viruses and often special immunizations that have a stronger dose of dead virus to create immunity. Autoimmune diseases: If you take suppressive medications for autoimmune diseases (Biologics) It is very important that you take good care of yourself and try to be as healthy as possible. Diabetes must be kept in control and your blood sugar and insulin within normal limits. AIDS Patients Cancer Patients Patients over 65 yo All chronic diseases If you are a high-risk patient or you can't lower all of your risk factors, then you may want to check to see if your immunization or recent infection gave you immunity.  It will take a blood test to determine your immune status, and to see if you need a booster shot. The current test can be done at Quest and is an IGG and IGM test for a specific virus. It tells you if you have made antibodies to a specific virus or not. You may be checking to see if your immunization worked or if you still have antibodies to an infection that you had, to confirm your immunity. If you are at high risk and can't take an immunization or can't develop immunity after an immunization or infection, then you will have to continue to avoid crowds, wear masks and take supplements to fortify your immune system.  These are my suggestions for all viral illnesses like the flu, covid, pneumonia, shingles and other viruses for which we have immunizations.  I hope this helps you make proper choices about activity, and immunization and that this talk assists you in improving your immunity as much as possible.

Orlando Sentinel Conversations
#OSNow: Orange County on mend after sky-high-COVID infections, and Disney's new Space 220 restaurant at Epcot (Ep. 740)

Orlando Sentinel Conversations

Play Episode Listen Later Sep 20, 2021 10:25


Orlando Sentinel Now afternoon update for Tuesday, Sept. 21, 2021. Orange County on mend after sky-high COVID-19 infections and deadly August (:33) First look: Epcot's Space 220 restaurant opens (5:20)

Spectrum | Deutsche Welle
Why Germany will wait on vaccinating young kids

Spectrum | Deutsche Welle

Play Episode Listen Later Sep 20, 2021 14:15


The BioNTech-Pfizer vaccine appears to be safe and extremely effective in 5-to-11-year-olds — even at low doses. But when can parents actually vaccinate them? Also, a look at an ongoing experiment involving dogs, an aging rock band and a whole lot of sweat.

MedCram
18. COVID Vaccine Myths, Questions, and Rumors with Rhonda Patrick and Roger Seheult

MedCram

Play Episode Listen Later Sep 18, 2021 143:56


Dr. Patrick joins MedCram to discuss COVID 19 vaccines, spike protein, ivermectin, VAERS, breakthrough Infections, antibody dependent enhancement, fertility, delta variant, myocarditis, fluvoxamine, optimizing immunity, and more. Dr. Rhonda Patrick is a cell biologist with a Ph.D. in biomedical science from the University of Tennessee Health Science Center and St. Jude Children's Research Hospital. Dr. Patrick is the Co-Founder of FoundMyFitness.com. Subscribe to Dr. Patrick's YouTube channel here: https://www.youtube.com/user/FoundMyFitness?sub_confirmation=1 Roger Seheult, MD is the co-founder and lead professor at https://www.medcram.com. He is an Associate Professor at the University of California, Riverside School of Medicine and Assistant Professor at Loma Linda University School of Medicine. Dr. Seheult is Quadruple Board Certified: Internal Medicine, Pulmonary Disease, Critical Care, and Sleep Medicine. Interviewer: Kyle Allred, Physician Assistant, Producer, and Co-Founder of MedCram.com All coronavirus updates are at MedCram.com (including more discussion on delta variant covid, delta plus variant COVID, COVID delta variant, COVID 19 Delta Variant, rapid antigen testing, nasal vaccines, and more). THE MEDCRAM WEBSITE: Visit us for videos on over 60 medical topics and CME / CEs for medical professionals: https://www.medcram.com MedCram offers group discounts for students and medical programs, hospitals, and other institutions. Contact us at customers@medcram.com if you are interested. DISCLAIMER: MedCram medical videos and podcasts are for medical education and exam preparation, and NOT intended to replace recommendations from your doctor.

4sight Friday Roundup (for Healthcare Executives)
Public Health Reporting and Hospital Infections in the Pandemic Age

4sight Friday Roundup (for Healthcare Executives)

Play Episode Listen Later Sep 17, 2021 21:26


Public Health Reporting and Hospital Infections in the Pandemic Age What other shortcomings did COVID-19 expose in the healthcare delivery system in the U.S.? We talked about two of them and what to do about it on today's episode of the 4sight Friday Roundup podcast. Here the week's biggest news around market-based change. David Johnson is CEO of 4sight Health. Julie Vaughan Murchinson is Partner of Transformation Capital and former CEO of Health Evolution. David Burda is News Editor and Columnist of 4sight Health. Subscribe on iTunes, Spotify, other services. Click play to listen to the 9/17/2021 Episode.

Podcast – The Burning Truth
COVID Infections Of The Vaccinated Continue To Rise – Wednesday, Sept. 15 – Hour 2

Podcast – The Burning Truth

Play Episode Listen Later Sep 17, 2021 29:17


__ Follow Casey on Facebook, Twitter, & Snapchat @CaseyTheHost__ Daily Show Prep: Wednesday, Sept. 15 The post COVID Infections Of The Vaccinated Continue To Rise – Wednesday, Sept. 15 – Hour 2 appeared first on The Burning Truth.

HealthcareNOW Radio - Insights and Discussion on Healthcare, Healthcare Information Technology and More
4sight Roundup: News on 09-17-2021 - Public Health Reporting and Hospital Infections in the Pandemic

HealthcareNOW Radio - Insights and Discussion on Healthcare, Healthcare Information Technology and More

Play Episode Listen Later Sep 17, 2021 21:27


Public Health Reporting and Hospital Infections in the Pandemic Age David Johnson and Julie Murchinson talked about hospitals' ability to report public health data and control inpatient infections on the new episode of the 4sight Friday Roundup podcast moderated by David Burda. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen/

SBS World News Radio
A 'hemispheric surge' of COVID infections in the West

SBS World News Radio

Play Episode Listen Later Sep 16, 2021 6:53


World health officials say North and Central America are driving what they're calling a 'hemispheric coronavirus surge'.

All Sides with Ann Fisher
Wellness Wednesday: Breakthrough Infections Less Likely To Lead To Long COVID

All Sides with Ann Fisher

Play Episode Listen Later Sep 15, 2021 50:01


This week on Wellness Wednesday, we'll look at how likely breakthrough infections are to cause long COVID, the healthiness of plant-based meat products and a preview of the upcoming flu season.

The First Lady of Nutrition Podcast with Ann Louise Gittleman, Ph.D., C.N.S.
Post Covid Long Haul Syndrome and Chronic Fatigue – Episode 88: Dr. Jacob Teitelbaum

The First Lady of Nutrition Podcast with Ann Louise Gittleman, Ph.D., C.N.S.

Play Episode Listen Later Sep 15, 2021 32:16


Join Ann Louise and the renown Dr. Jacob Teitelbaum as they discuss the long-awaited updated version of his revolutionary and groundbreaking book “From Fatigued to Fantastic.”  As Dr. Teitelbaum explains millions of Americans suffer needlessly from fatigue, pain, chronic fatigue syndrome (CFS), and fibromyalgia (FMS) and the good news is, they don't have to! The First Lady and Dr. Teitelbaum dive into the current COVID-19 crisis and how 10 – 25% of people who come down with the virus will have persistent severe symptoms.  He offers his no-nonsense solutions to post-viral chronic fatigue syndrome and fibromyalgia and discusses his seven studies on effective treatment which can be found at:  www.Vitality101.com  and www.EndFatigue.com.   Dr. Teitelbaum also explains, the success of his randomized double-blind placebo-controlled study using the SHINE Protocol – which optimizes Sleep, Hormones/Hypotension, Infections, Nutrition, and Exercise.  This chock-full episode is one of our best to date!  The post Post Covid Long Haul Syndrome and Chronic Fatigue – Episode 88: Dr. Jacob Teitelbaum appeared first on Ann Louise Gittleman.

Short Wave
Breakthrough Infections, Long COVID And You

Short Wave

Play Episode Listen Later Sep 14, 2021 10:27


In rare cases, the delta variant of the coronavirus is causing vaccinated people to get sick — so-called "breakthrough infections." Now researchers are asking: Could these infections lead to long COVID, when symptoms last weeks and months? Today, science correspondent Rob Stein makes sense of the latest data, explaining what we know so far about long COVID in vaccinated people.Read more of Rob's reporting here: https://www.npr.org/sections/health-shots/2021/09/13/1032844687/what-we-know-about-breakthrough-infections-and-long-covid

Scroll Down: True Stories from KYW Newsradio
If you are fully vaccinated, what is your risk of getting COVID-19? Q&A about Delta, breakthrough infections, and long COVID

Scroll Down: True Stories from KYW Newsradio

Play Episode Listen Later Sep 13, 2021 19:21


If you are fully vaccinated, what is your risk of getting COVID-19? How bad can breakthrough infections get? How contagious are you, if you get the virus and you're vaccinated? What are the concerns of long COVID in fully vaccinated people? These are questions on a lot of minds right now, so we asked them to Dr. Annette Reboli, Professor of Medicine and the Dean of the Cooper Medical School at Rowan University in South Jersey. Learn more about your ad choices. Visit podcastchoices.com/adchoices

American Conservative University
American Thought Leaders- PART 1. Dr. Robert Malone, mRNA Vaccine Inventor, on Latest COVID-19 Data

American Conservative University

Play Episode Listen Later Sep 11, 2021 41:21


American Thought Leaders- PART 1. Dr. Robert Malone, mRNA Vaccine Inventor, on Latest COVID-19 Data AMERICAN THOUGHT LEADERS https://www.theepochtimes.com/c-american-thought-leaders  PART 1: Dr. Robert Malone, mRNA Vaccine Inventor, on Latest COVID-19 Data, Booster Shots, and the Shattered Scientific ‘Consensus' “We need to confront the data [and] not try to cover stuff up or hide risks,” says mRNA vaccine pioneer Dr. Robert Malone. What does the most recent research say about the efficacy of COVID-19 vaccines? In this two-part episode, we sit down again with Dr. Malone for a comprehensive look at the vaccines, booster shots, repurposed drugs like ivermectin, and the ethics of vaccine mandates. Jan Jekielek: Dr. Robert Malone, it's such a pleasure to have you back on American Thought Leaders. Dr. Robert Malone: Always my pleasure, Jan, and thank you for the chance to come back and visit. Mr. Jekielek: I want to read you a few headlines that I've come across in the last few weeks since we did our recent interview, and give you a chance to speak to them. This is a drophead: “Robert Malone claims to have invented mRNA technology. Why is he trying so hard to undermine its use?” How do you react to this? Dr. Malone: That's the Atlantic hit piece. It was a very interesting article because it has a number of logic jumps and irregularities. Then it ends up contradicting itself in the last paragraph, and basically confirming that my assertions about having being the originator of the core technology are valid. I'm subjected to this meme that you didn't really do the things that you did in the late 1980s almost continuously, usually from internet trolls.  So really what the young author was picking up on was some internet memes that have been wrapped around the prior press push that Katie Kariko and Drew Weissman were the ones that had originated the technology. Now that was clearly false, but it was very actively promoted by their university, which holds a key patent, and then advanced through Stat News, Boston Globe, CNN, and then finally the New York Times. We challenged that, and in the case of the New York Times, they actually recut their interview and podcast with Katie Kariko to cut out the parts where she had claimed that she was the original inventor.  But how do I react to it, this kind of pejorative use of language to cast shade? It doesn't really bother me. I know what the facts are, and I have this massive amount of documentation. When people come at me with those things, I just say, “Hey, look, here it's on the website. Here are the documents, you can make your own assessment.”  The thing that bothers me about all of this, when they're personalizing character assassination on me and character attacks, is that it distracts from the issues. And it's not about me, this kind of chronic questioning of why would I be saying things about the ethics of what's going on? Why would I be raising concerns about the safety signals? I must have some ulterior motive.  There's an underlying theme to all this, that I must have some ulterior motive. This particular journalist asked me again, and again, and again, trying to get at, “What was my ulterior motive for trying to undermine these vaccines based on my technology?” It was so paradoxical, the push of a whole series of questions that he raised with me.  I don't know what it says about journalism or what it says about our culture, that we always assume that someone must have an ulterior motive. It's not sufficient to just be addressing an issue because it matters, because it is the ethically correct thing to do. There seems to be this assumption that everybody's got an angle. It says more about the author than it says about me.  This kind of casting shade and aspersions on me personally as a way to avoid addressing the underlying issues, I just see it as a kind of noise and also a little bit sad. It's almost an affirmation. If the strongest thing they can come up with is to try to attack and cast shade on whether or not I made a significant contribution that led to over nine patents during the late 1980s—if that's the worst they can throw at me, I'm doing pretty good. So that's how I see it. Mr. Jekielek: So you're not trying, “So hard to undermine the use of this vaccine technology.” Dr. Malone: No. My concern here, as I said in our prior interview, is that there's been a series of actions taken, policies taken, regulatory actions taken, that are at odds with how I've been trained with the norms as I've always understood them. The regulatory norms, the scientific norms—these things have been waived. For a lot of people, it doesn't make sense.  And recall, reeling back, what triggered this was this amazing podcast with Bret Weinstein and Steve Kirsch, where I don't think at that point in time the world had really heard anyone questioning the underlying safety data assumptions and ethics of what was being done. There was a widespread sense of unease about these mandates and efforts to force vaccinations, and expedite the licensure of this and deploy it globally on the basis of very abbreviated clinical trials. There was a widespread sense of uneasiness.  But people didn't really have language to express it. When that podcast happened, for some reason, it catalyzed global interest in a way that I didn't expect. I still have people writing me, “I just saw the Bret Weinstein DarkHorse Podcast.” Something happened there, where events came together. I expressed some things that I had just been observing that I felt were anomalous in how the government was managing the situation, in the nature of the vaccines, in the testing of the vaccines, and in the ethics of how they were being deployed and forced on children, plus other things in various countries, including the United States.  That triggered a whole cascade, but it wasn't because I had concerns about the technology or was casting shade on the technology, I've repeatedly made it clear that, in my opinion, these vaccines have saved lives. I get challenged on that all the time, by the way. There's a whole cohort that says, “Oh no, these aren't worth anything. They shouldn't be used at all. They're not effective.”  In my opinion, they've saved a lot of lives and they're very appropriate at this point in time. The risk benefit favors administration of these vaccines, even with all we've learned since in these last few months, it favors their administration to the elderly and the high-risk populations. So contrary to this thread of I'm trying to denigrate these and tear them down—no, I'm trying to say I'm all in favor, strongly in favor of ethical development and deployment of vaccines that are safe, pure, effective, and non-adulterated.  I'm really strongly dug in that we need to confront the data as it is, and not try to cover stuff up or hide risks or avoid confronting risks. In my opinion, the way that we get to good public policy  in public health is we not only recognize those risks, but we also constantly take the position of looking forward, looking for leading indicators of risk, performing risk mitigation, and monitoring for black swans and unexpected events surrounding that. That's where I come from, strongly believing that the norms that have been developed over the last 30 to 40 years in vaccinology should be maintained. We shouldn't jettison them just because we're having a crisis. Mr. Jekielek: Why don't we do a review? There's been a number of very significant papers in the last week or two that have come out with very robust data sets telling us, to my less educated eye, some very valuable information. If you agree, maybe you can review some of these for us. I know you've been studying every one of these in some detail. Dr. Malone: The emergence of the Delta variant, whether originally in India and then subsequently in the UK and then in Israel, has really thrown back the public health enterprise globally and in these countries, because there were assumptions made about the effectiveness of the current vaccines and their ability to contain the outbreak. There was almost a social contract set up between the vaccine recipients and the governments and public health authorities. That social contract was, “Despite what you may have heard about the risks of some of these products and the fact that we admittedly did rush them, we're protecting your health. If you take these products, you will be safe.” That's the social contract. “Despite all these other concerns, you will be safe, and you won't have to retake them. You'll be protected.” People believed they had a shield if they bought in and did this. And then the Delta variant came along, and suddenly that was no longer valid. The assumption that had been made, the social contract, was somehow broken. First we found out, if you'll recall this cascade of events—we had Pfizer disclose that the durability, the length of time that the vaccine would provide protection was not as expected. It was something like six months. This came out of the Israeli data. Mr. Jekielek: Just to be clear, are we talking about protection from infection or protection from disease? Dr. Malone: That's a whole other rabbit hole. It really was protection from infection and spread that was the main parameter of concern with the six month data. You may recall that announcement was made unilaterally by Pfizer based on the Israeli data, and then immediately contradicted by Dr. Fauci saying that this wasn't true and Pfizer had no right to make these statements, and they hadn't discussed it with him. Pfizer then apologized and backed down.  And a week later, the U.S. government announced, that in fact, we were going to need to have boosters. Then there was the announcement that the government had contracted to buy the boosters that were going to be deployed at eight months. Then more data came out. Now most recently the government is saying, “We may have to have boosters at five months.” There was emergency use authorization that this third dose would be deployed to elderly and immunocompromised. And now we're talking about everybody needing it.  So this was the logic, “Take the dose, take the two shots or the one-shot for J&J and you'll be protected. We'll get out of this because we'll reach herd immunity. The whole problem is that we just don't have enough people that are being compliant with this.” Remember, this goes back to July 4th.  July 4th was the goal when we were going to have 70 per cent vaccine uptake. We didn't meet that. And there was a lot of discomfort with the Israeli data. Then all of this new information is rolled out, the Israeli data in particular, having to do with the increasing number of infections and hospitalizations.  At first the position was that this was only occurring in the unvaccinated cohort. Then that became increasingly untenable and it became clear that it was occurring in the vaccinated cohort. The same became true with the UK data set, which is stronger than the American monitoring system. They do a lot more sequence analysis.  So now we had this paradox that those that had been vaccinated, while the data still suggested that they're largely protected from disease and death and more protected than the unvaccinated from disease and death, they're no longer protected from infection. It became clear within the data, and through multiple sources, that the levels of virus replication in the individuals, even who had been vaccinated previously, was the same or higher as the levels of virus replication in those that had been un-vaccinated. And also that those that had been vaccinated and had breakthrough infections, which is what we're talking about, were also shedding virus and able to spread virus.  So that raised the prospect that they were kind of the new super spreaders, because they would have less apparent disease and yet still be shedding high levels of virus. Then we started to see some signs suggesting that there may be some differences in the nature or onset or titers of disease in those that had been infected beyond six months after their vaccination point. This is the waning phase.  That set up a situation where a lot of folks were on edge. There were still a lot of media pushing that this was a pandemic of the unvaccinated, but that became increasingly untenable as the data rolled in. You've referred to this paper that came out. There were actually three in a row that came out almost immediately after the license was issued for the BioNTech product.  There was a paper published in the New England Journal of Medicine that had an odd structure in which they related adverse events associated with the virus infection and a much more comprehensive assessment of adverse events associated with the vaccines. By juxtaposing these two data sets in the same manuscript, the case was made that, “Yes, we have this significantly enhanced spectrum of adverse events associated with the vaccine beyond what had been previously disclosed. We were all focused on the cardio-toxicity.”  But now, additional adverse events, and things that we discussed when we had our last chat as parent adverse events, these are now fairly well-documented in this New England Journal article, things like viral reactivation. So this is the shingles, for instance.  The paper attempts to make the case that, “The vaccines have a lot of adverse events, but the disease has a lot of adverse events also, and the disease is worse. Also there's a lot of overlap between these adverse events associated with the disease and the vaccine.” But the messaging was focused in that manuscript that it was far worse to get the disease than to have the adverse events associated with the vaccine.  That's a little bit of a false analogy, because the vaccine ostensibly would be deployed to 80 or 90 per cent of the population. And in terms of this wave of Delta, we might see something like 20 or 30 per cent of the population infected if we're lucky. Then there's an imbalance of who's at risk with the vaccine versus who's at risk for the infection, but that was the construct. Mr. Jekielek: And just to be clear, what do you mean by 20 to 30 per cent, if we're lucky? Where do those numbers come from? Dr. Malone: I've seen data suggesting that the total population right now that's been infected in the United States is something like about 20 per cent of the total population. We don't have that widespread of an uptake of infection in the U.S. or in the UK. UK data also shows those kinds of numbers. They're reflected in a cohort that have had a natural infection and recovered from that, and then acquired the immune response associated with that.  It's seen in the numbers, for instance, in those cases where there is an accounting, such as in the Great Britain database, the British database, where they say the fraction of the population that's been vaccinated, and then the fraction of the population that's acquired natural immunity. It's also covered in the CDC slide deck that was leaked. I don't think that was available when we had our last conversation.  At the early outset, at the front edge of the Delta outbreak here in the United States, there was a key slide deck that was disclosed to the Washington Post without approval by a CDC employee. Within that slide deck, it showed a number of confidential internal assessments that weren't intended to be shared with the public. Those assessments also included an estimate that we had something like 50 per cent of the population that had accepted vaccine at that point in time. In addition, there was something like 20 per cent of the population that had been infected.  So if you add those two, if you were to consider natural infection as providing some degree of protection against the virus, then we would move from something like 50 per cent vaccine uptake to something like 70 per cent of the population at that point in time that had actually acquired some form of immunity either through vaccination or infection. So that's the basis of my seat-of-the-pants estimate.  In addition, in the CDC slide deck, the government revealed in two key slides that were at the center of that deck, that their epidemiologic calculations and projections were such that the reproductive coefficient of Delta was something in the range of eight. There's other papers that suggest it's more like a little over five, that it was as infectious as chickenpox approximately, which is highly infectious, about two to three times more infectious than the Alpha strain was.  Based on those projections and some assumptions about the percent of the population that had been naturally infected, and the percent of the population that had taken up vaccine, and some assumptions about the effectiveness of mask use in protecting either an individual from being infected by a third party that wasn't using masks or protecting a third party from infection from somebody that was using a mask and was infected—there were a series of projection curves about how that could impact on the spread of the virus.  Basically when you work through those curves, what they demonstrated was that even if we had 100 per cent vaccine uptake with these vaccines, where the technical term is leaky, that do not provide perfect protection against infection, that we would not be able to stop the spread of the virus through the U.S. population. We would slow it. So that's where those estimates come from.  That's where that assessment that is being used as the basis for advocating widespread mask deployment throughout the United States, that's where that policy comes from. It's a CDC analysis that if we don't use masks, then the virus will spread quite rapidly. If we do have full compliance with mask use, we can slow it down a bit. And so that's why we have these various mask mandates throughout the United States now. Mr. Jekielek: Fascinating. You started talking about natural immunity here. I thought it was some of the most interesting, robust data, at least to my eye. Again, you're the one who's going to be speaking on this. Dr. Malone: I agree, and a lot of people agree. It was covered in Science magazine. It's still a pre-print, but it was robust enough, and well enough constructed that even on the basis of the pre-print, Science magazine went ahead and made the clear point. Really, throughout the world, there was recognition that this new data coming out of Israel, as I recall, demonstrated that the term that's often used is natural immunity. It's an odd term, but it's now in common language.  What that means is protection afforded by having been infected and recovered from infection, which will generate a broad immune response. And it's now been shown in that paper and others that the breadth of that immune response in terms of memory T and B cell populations is more diverse and more long lasting than the breadth of immune response elicited by the spike based vaccines alone.  That data that you're alluding to showed that this natural immunity is broader and more durable, which contradicted some studies that the CDC had developed. So we were in a kind of tension. Which is the real data, the CDC data, or these other papers that are evaluated memory T and B cell populations? Which is true? We have multiple truths or multiple pieces of data, plus different groups claiming it's one way or the other.  Then this data was dropped about the evidence of protection. It seems to indicate and be consistent with the claims that the breadth and durability of the immune response was superior with the natural infection in recovery. There's also evidence that there's a significant, depending on the timeframe, six to twenty-fold improvement in protection from infection and disease associated with the natural immunity acquired from prior infection, compared to that conferred by the vaccine.  So now the public, in their social contract with the public health agencies, is faced with the situation where they had been told that natural immunity was not as protective, and that they can't rely on that. If you've been previously infected, you should still get both doses of vaccine, and this vaccination would provide broad, durable protection. It would protect you, and it would protect your elders from you potentially spreading disease to them.  Now, those things have all come into question. The population is still reeling from that. We have kind of dug into these camps. My sense is that people haven't really fully processed what this means. It is profound.  We were discussing before we started shooting, that I had a long podcast interview today and a kind of advisory session with a group of Latin American physicians and scientists that were evaluating public policy for vaccine rollout versus early treatment options for the different cohorts that they have to protect. They were seeing this data from the eyes of folks that really haven't had good access to vaccines, but are facing the prospects that their countries could execute vaccine contracts and bring in these vaccines. They are asking the question, “Does this make sense for us? Is this good policy? Should our country invest in these mRNA vaccines?”  That is why they were talking to me. “What are we going to get for it if we do this? What's going to be the benefit to our population?” It was a very level-headed discussion. But they were pushing me in this, getting back to this theme of me being the vaccine skeptic. They were the ones pushing me saying, “We just don't see the value here for our populations. We don't see a compelling case when these products aren't stopping the spread. They are going to have to be re-administered fairly frequently if they're to be effective?”  Now, the other thing that comes out of this, a concern that the World Health Organization hasn't really come to terms with—I'm speaking of the CDC and the WHO and the whole global infrastructure, including the Israeli government—is one of now mandating a third jab. So in Israel, if you haven't received all three, you're not considered fully vaccinated. Mr. Jekielek: You have a six month window, if I'm not mistaken. Dr. Malone: Precisely. But one of the things about the Israeli data is that they vaccinated in such a bolus, in such a short push, because they have such a compliant population, that essentially, they have a spike in vaccinated persons. So they're all moving concurrently through that six month window now.  There was a pivotal interview with the director of the CDC and she was asked, “Do we have any data? Do we have data, or do we just have hope about the benefits of the third dose?” And she, to her credit, acknowledged that we don't have data. All we have is hope.  Here's the problem with that. Vaccine responses are not linear. More is not better. There are many cases where if you dose more or dose more frequently or move beyond a prime and a boost, you can actually quench the immune response. You can move into “high zone tolerance.” You can move into a situation where your immune responses drop.  Now there's a little bit of foreshadowing on this in another paper that's out where they looked at the effects of vaccination post-infection. Remember this was the policy, that those like me that have been infected should go ahead and take two jabs, take two doses of vaccine. Mr. Jekielek: Which you did. Dr. Malone: Which I did, hoping that it would be helpful for a long COVID period. That data hasn't really played out that way. And there's a paper showing that you can actually quench T-cell responses. You get an improved kind of a super immune response, they assert in that manuscript, after a single dose when you've been previously infected. But with the second dose, your T-cell population actually gets quenched, which is consistent with high zone tolerance.  So if that paper was to be expanded and verified with more robust numbers, it would suggest that one dose after natural infection would be a good thing. Two doses would be a bad thing. Now that's the equivalent of three doses if you think about it, natural infection being dose one. So to say that we don't have any data is a little misleading. We have some leading indicators that suggest that it might not be such a good idea. And now, that data will come out from Israel. The conservative position to take is time will tell, and then we will know.  The Israelis continue to be in the throes of a very active Delta virus infection surge right now. There's some other very intriguing tidbits going on here in this whole public policy of vaccines versus no vaccines, versus universal vaccines, versus the Barrington position that we should selectively vaccinate those that are at high risk. Mr. Jekielek: The Great Barrington Declaration? Dr. Malone: Yes, the Great Barrington Declaration. After that whole matrix of decisions, in comes Sweden. You may recall that Sweden was roundly criticized for this naive notion that they weren't going to vaccinate. They were going to allow the virus to have its will with the population. They have backtracked from that now, to be technically accurate. They have about 40 per cent vaccine uptake and they've acknowledged that position was naive and counterproductive. They had excess deaths initially in the high-risk cohorts.  But what they did do was have a lot more natural infection with alpha and beta strains. And now that Delta is moving through the region, they have an extremely low mortality rate, often hitting zero on any one day—in comparison to some of their neighbors that didn't take that policy, and didn't have such widespread natural infection. Like Finland, for example, where they deployed vaccine very avidly and had good uptake, they're having the exponential growth rate curve that's happening in many other Northern European countries right now. Mr. Jekielek: I'm going to comment here. This is very interesting because you're interpreting this data a bit differently than Dr. Martin Kulldorff, who is from Sweden.  His commentary in a recent interview we did was simply that there were no mandates of any sort ever in Sweden, yet their vaccine use is actually quite high. He said it's one of the higher rates that exist. But he didn't factor in this time period that you said at the beginning, where there was this idea of letting the natural infections happen. And you're saying the reason their rates are zero mortality is because of that. Dr. Malone: Yes. It is a very reasonable explanation for what's happened there. It's a differentiator between them and some of their neighboring countries. They did have that early policy and they did have fairly widespread infection. So that would be consistent with the data suggesting that natural infection is providing broader and more durable immunity.  This gets to the logic of a selective deployment of vaccines to those that are at highest risk. For that fragment of the population, let's say below 65, depending on where you want to cut the line, 60, 65, 70, some people go down to 55, not providing vaccine coverage to those individuals unless they're in a very high risk population, morbidly obese, or with immunologic deficiencies—that may be a more enlightened public policy.  By the way, it is one more consistent with the WHO position that we still have limited vaccine supply, and it would be far more appropriate and equitable to deploy that vaccine supply more broadly globally to protect the elders in particular throughout the world, rather than this focus on universal vaccination.  Now with a booster, a third booster, a third dose, there's been multiple statements by the WHO that they believe this is not ethical. Now, I had another interview today with a journalist podcaster who is from South Africa but living in France, and very aware of the French resistance that's developing now to vaccines with all those protests. Mr. Jekielek: To vaccine mandates, correct? Dr. Malone: In particular, yes. His point was that if you look at this through the eyes of emerging economies, this Western focus on universal vaccination of their populations and now a third vaccine for their populations and their unwillingness to share the technology is a form of imperialism and hegemony. The Western nations have access to this technology and these doses and they're not willing to share it with the rest of the world.  So we've got a series of things here where this kind of imbalance in distribution of these vaccines as a resource is creating or exacerbating concerns that exist widely in economically disadvantaged countries. There's just not a level playing field and we're all in this boat together with this disease. Yet we're not being equitable in distribution of the countermeasures that are available. Mr. Jekielek: This is fascinating, even as others that you're speaking with are asking, “Do we even need these at this point?” That's fascinating. Dr. Malone: Yes, I agree. So what does this mean? I don't know. What I sense is, again, we're in one of those moments where there is chaos. There's lack of structure and consensus about how to move forward. And my sense is, getting back to the U.S. government, we're in a position now where a lot of the core assumptions underlying the vaccine strategy have been called into question. We don't really know what's on the other side.  Then on top of that, it's becoming increasingly apparent that these repurposed drugs and other agents that could provide protection and mitigate death and disease, if they were deployed early in outpatient environments, access to those that are being actively suppressed. That's another one of those, “This doesn't make sense,” kind of problems. It is causing a lot of questioning about the motivations of those that are guiding public policy right now. The second part of this episode will be released on Saturday, Sept. 4, at 7 p.m. ET. Below is a list of references mentioned or related to the discussion in this episode:  “Vaccinated and unvaccinated individuals have similar viral loads in communities with a high prevalence of the SARS-CoV-2 delta variant” (Note: This is a preprint). “Fauci: Amount of virus in breakthrough delta cases ‘almost identical' to unvaccinated” — The Hill CDC: “Outbreak of SARS-CoV-2 Infections, Including COVID-19 Vaccine Breakthrough Infections, Associated with Large Public Gatherings — Barnstable County, Massachusetts, July 2021” “Predominance of antibody-resistant SARS-CoV-2 variants in vaccine breakthrough cases from the San Francisco Bay Area, California” (Note: This is a preprint) “New delta variant studies show the pandemic is far from over” — ScienceNews “Read: Internal CDC document on breakthrough infections” — The Washington Post “New UCSF study: Vaccine-resistant viruses are driving ‘breakthrough' COVID infections” — The Mercury News “Comparing SARS-CoV-2 natural immunity to vaccine-induced immunity: reinfections versus breakthrough infections” (Note: This is a preprint) “Having SARS-CoV-2 once confers much greater immunity than a vaccine—but vaccination remains vital” — Science “Differential effects of the second SARS-CoV-2 mRNA vaccine dose on T cell immunity in naïve and COVID-19 recovered individuals” (Note: This is a preprint) “SARS-CoV-2 variants of concern and variants under investigation in England” — Public Health England “Safety of the BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting” — The New England Journal of Medicine “Real-World Study Captures Risk of Myocarditis With Pfizer Vax” — MedPage Today CDC: “Effectiveness of COVID-19 Vaccines in Preventing SARS-CoV-2 Infection Among Frontline Workers Before and During B.1.617.2 (Delta) Variant Predominance — Eight U.S. Locations, December 2020—August 2021” “CDC: Covid-19 Vaccine Effectiveness Fell From 91% To 66% With Delta Variant“ — Forbes “SARS-CoV-2 infection induces long-lived bone marrow plasma cells in humans” — Nature CDC: “Reduced Risk of Reinfection with SARS-CoV-2 After COVID-19 Vaccination — Kentucky, May-June 2021” “Causes and consequences of purifying selection on SARS-CoV-2” — Genome Biology and Evolution “The reproductive number of the Delta variant of SARS-CoV-2 is far higher compared to the ancestral SARS-CoV-2 virus” — Journal of Travel Medicine “Mutation rate of COVID-19 virus is at least 50 percent higher than previously thought” — Phys.org “Differential effects of the second SARS-CoV-2 mRNA vaccine dose on T cell immunity in naïve and COVID-19 recovered individuals” (Note: This is a preprint) Subscribe to the American Thought Leaders newsletter so you never miss an episode. You can also follow American Thought Leaders on Parler, Facebook, or YouTube. If you'd like to donate to support our work, you can do so here. Follow Epoch TV on Facebook and Twitter. 

American Conservative University
American Thought Leaders- PART 1. Dr. Robert Malone, mRNA Vaccine Inventor, on Latest COVID-19 Data

American Conservative University

Play Episode Listen Later Sep 11, 2021 41:21


American Thought Leaders- PART 1. Dr. Robert Malone, mRNA Vaccine Inventor, on Latest COVID-19 Data AMERICAN THOUGHT LEADERS https://www.theepochtimes.com/c-american-thought-leaders  PART 1: Dr. Robert Malone, mRNA Vaccine Inventor, on Latest COVID-19 Data, Booster Shots, and the Shattered Scientific ‘Consensus' “We need to confront the data [and] not try to cover stuff up or hide risks,” says mRNA vaccine pioneer Dr. Robert Malone. What does the most recent research say about the efficacy of COVID-19 vaccines? In this two-part episode, we sit down again with Dr. Malone for a comprehensive look at the vaccines, booster shots, repurposed drugs like ivermectin, and the ethics of vaccine mandates. Jan Jekielek: Dr. Robert Malone, it's such a pleasure to have you back on American Thought Leaders. Dr. Robert Malone: Always my pleasure, Jan, and thank you for the chance to come back and visit. Mr. Jekielek: I want to read you a few headlines that I've come across in the last few weeks since we did our recent interview, and give you a chance to speak to them. This is a drophead: “Robert Malone claims to have invented mRNA technology. Why is he trying so hard to undermine its use?” How do you react to this? Dr. Malone: That's the Atlantic hit piece. It was a very interesting article because it has a number of logic jumps and irregularities. Then it ends up contradicting itself in the last paragraph, and basically confirming that my assertions about having being the originator of the core technology are valid. I'm subjected to this meme that you didn't really do the things that you did in the late 1980s almost continuously, usually from internet trolls.  So really what the young author was picking up on was some internet memes that have been wrapped around the prior press push that Katie Kariko and Drew Weissman were the ones that had originated the technology. Now that was clearly false, but it was very actively promoted by their university, which holds a key patent, and then advanced through Stat News, Boston Globe, CNN, and then finally the New York Times. We challenged that, and in the case of the New York Times, they actually recut their interview and podcast with Katie Kariko to cut out the parts where she had claimed that she was the original inventor.  But how do I react to it, this kind of pejorative use of language to cast shade? It doesn't really bother me. I know what the facts are, and I have this massive amount of documentation. When people come at me with those things, I just say, “Hey, look, here it's on the website. Here are the documents, you can make your own assessment.”  The thing that bothers me about all of this, when they're personalizing character assassination on me and character attacks, is that it distracts from the issues. And it's not about me, this kind of chronic questioning of why would I be saying things about the ethics of what's going on? Why would I be raising concerns about the safety signals? I must have some ulterior motive.  There's an underlying theme to all this, that I must have some ulterior motive. This particular journalist asked me again, and again, and again, trying to get at, “What was my ulterior motive for trying to undermine these vaccines based on my technology?” It was so paradoxical, the push of a whole series of questions that he raised with me.  I don't know what it says about journalism or what it says about our culture, that we always assume that someone must have an ulterior motive. It's not sufficient to just be addressing an issue because it matters, because it is the ethically correct thing to do. There seems to be this assumption that everybody's got an angle. It says more about the author than it says about me.  This kind of casting shade and aspersions on me personally as a way to avoid addressing the underlying issues, I just see it as a kind of noise and also a little bit sad. It's almost an affirmation. If the strongest thing they can come up with is to try to attack and cast shade on whether or not I made a significant contribution that led to over nine patents during the late 1980s—if that's the worst they can throw at me, I'm doing pretty good. So that's how I see it. Mr. Jekielek: So you're not trying, “So hard to undermine the use of this vaccine technology.” Dr. Malone: No. My concern here, as I said in our prior interview, is that there's been a series of actions taken, policies taken, regulatory actions taken, that are at odds with how I've been trained with the norms as I've always understood them. The regulatory norms, the scientific norms—these things have been waived. For a lot of people, it doesn't make sense.  And recall, reeling back, what triggered this was this amazing podcast with Bret Weinstein and Steve Kirsch, where I don't think at that point in time the world had really heard anyone questioning the underlying safety data assumptions and ethics of what was being done. There was a widespread sense of unease about these mandates and efforts to force vaccinations, and expedite the licensure of this and deploy it globally on the basis of very abbreviated clinical trials. There was a widespread sense of uneasiness.  But people didn't really have language to express it. When that podcast happened, for some reason, it catalyzed global interest in a way that I didn't expect. I still have people writing me, “I just saw the Bret Weinstein DarkHorse Podcast.” Something happened there, where events came together. I expressed some things that I had just been observing that I felt were anomalous in how the government was managing the situation, in the nature of the vaccines, in the testing of the vaccines, and in the ethics of how they were being deployed and forced on children, plus other things in various countries, including the United States.  That triggered a whole cascade, but it wasn't because I had concerns about the technology or was casting shade on the technology, I've repeatedly made it clear that, in my opinion, these vaccines have saved lives. I get challenged on that all the time, by the way. There's a whole cohort that says, “Oh no, these aren't worth anything. They shouldn't be used at all. They're not effective.”  In my opinion, they've saved a lot of lives and they're very appropriate at this point in time. The risk benefit favors administration of these vaccines, even with all we've learned since in these last few months, it favors their administration to the elderly and the high-risk populations. So contrary to this thread of I'm trying to denigrate these and tear them down—no, I'm trying to say I'm all in favor, strongly in favor of ethical development and deployment of vaccines that are safe, pure, effective, and non-adulterated.  I'm really strongly dug in that we need to confront the data as it is, and not try to cover stuff up or hide risks or avoid confronting risks. In my opinion, the way that we get to good public policy  in public health is we not only recognize those risks, but we also constantly take the position of looking forward, looking for leading indicators of risk, performing risk mitigation, and monitoring for black swans and unexpected events surrounding that. That's where I come from, strongly believing that the norms that have been developed over the last 30 to 40 years in vaccinology should be maintained. We shouldn't jettison them just because we're having a crisis. Mr. Jekielek: Why don't we do a review? There's been a number of very significant papers in the last week or two that have come out with very robust data sets telling us, to my less educated eye, some very valuable information. If you agree, maybe you can review some of these for us. I know you've been studying every one of these in some detail. Dr. Malone: The emergence of the Delta variant, whether originally in India and then subsequently in the UK and then in Israel, has really thrown back the public health enterprise globally and in these countries, because there were assumptions made about the effectiveness of the current vaccines and their ability to contain the outbreak. There was almost a social contract set up between the vaccine recipients and the governments and public health authorities. That social contract was, “Despite what you may have heard about the risks of some of these products and the fact that we admittedly did rush them, we're protecting your health. If you take these products, you will be safe.” That's the social contract. “Despite all these other concerns, you will be safe, and you won't have to retake them. You'll be protected.” People believed they had a shield if they bought in and did this. And then the Delta variant came along, and suddenly that was no longer valid. The assumption that had been made, the social contract, was somehow broken. First we found out, if you'll recall this cascade of events—we had Pfizer disclose that the durability, the length of time that the vaccine would provide protection was not as expected. It was something like six months. This came out of the Israeli data. Mr. Jekielek: Just to be clear, are we talking about protection from infection or protection from disease? Dr. Malone: That's a whole other rabbit hole. It really was protection from infection and spread that was the main parameter of concern with the six month data. You may recall that announcement was made unilaterally by Pfizer based on the Israeli data, and then immediately contradicted by Dr. Fauci saying that this wasn't true and Pfizer had no right to make these statements, and they hadn't discussed it with him. Pfizer then apologized and backed down.  And a week later, the U.S. government announced, that in fact, we were going to need to have boosters. Then there was the announcement that the government had contracted to buy the boosters that were going to be deployed at eight months. Then more data came out. Now most recently the government is saying, “We may have to have boosters at five months.” There was emergency use authorization that this third dose would be deployed to elderly and immunocompromised. And now we're talking about everybody needing it.  So this was the logic, “Take the dose, take the two shots or the one-shot for J&J and you'll be protected. We'll get out of this because we'll reach herd immunity. The whole problem is that we just don't have enough people that are being compliant with this.” Remember, this goes back to July 4th.  July 4th was the goal when we were going to have 70 per cent vaccine uptake. We didn't meet that. And there was a lot of discomfort with the Israeli data. Then all of this new information is rolled out, the Israeli data in particular, having to do with the increasing number of infections and hospitalizations.  At first the position was that this was only occurring in the unvaccinated cohort. Then that became increasingly untenable and it became clear that it was occurring in the vaccinated cohort. The same became true with the UK data set, which is stronger than the American monitoring system. They do a lot more sequence analysis.  So now we had this paradox that those that had been vaccinated, while the data still suggested that they're largely protected from disease and death and more protected than the unvaccinated from disease and death, they're no longer protected from infection. It became clear within the data, and through multiple sources, that the levels of virus replication in the individuals, even who had been vaccinated previously, was the same or higher as the levels of virus replication in those that had been un-vaccinated. And also that those that had been vaccinated and had breakthrough infections, which is what we're talking about, were also shedding virus and able to spread virus.  So that raised the prospect that they were kind of the new super spreaders, because they would have less apparent disease and yet still be shedding high levels of virus. Then we started to see some signs suggesting that there may be some differences in the nature or onset or titers of disease in those that had been infected beyond six months after their vaccination point. This is the waning phase.  That set up a situation where a lot of folks were on edge. There were still a lot of media pushing that this was a pandemic of the unvaccinated, but that became increasingly untenable as the data rolled in. You've referred to this paper that came out. There were actually three in a row that came out almost immediately after the license was issued for the BioNTech product.  There was a paper published in the New England Journal of Medicine that had an odd structure in which they related adverse events associated with the virus infection and a much more comprehensive assessment of adverse events associated with the vaccines. By juxtaposing these two data sets in the same manuscript, the case was made that, “Yes, we have this significantly enhanced spectrum of adverse events associated with the vaccine beyond what had been previously disclosed. We were all focused on the cardio-toxicity.”  But now, additional adverse events, and things that we discussed when we had our last chat as parent adverse events, these are now fairly well-documented in this New England Journal article, things like viral reactivation. So this is the shingles, for instance.  The paper attempts to make the case that, “The vaccines have a lot of adverse events, but the disease has a lot of adverse events also, and the disease is worse. Also there's a lot of overlap between these adverse events associated with the disease and the vaccine.” But the messaging was focused in that manuscript that it was far worse to get the disease than to have the adverse events associated with the vaccine.  That's a little bit of a false analogy, because the vaccine ostensibly would be deployed to 80 or 90 per cent of the population. And in terms of this wave of Delta, we might see something like 20 or 30 per cent of the population infected if we're lucky. Then there's an imbalance of who's at risk with the vaccine versus who's at risk for the infection, but that was the construct. Mr. Jekielek: And just to be clear, what do you mean by 20 to 30 per cent, if we're lucky? Where do those numbers come from? Dr. Malone: I've seen data suggesting that the total population right now that's been infected in the United States is something like about 20 per cent of the total population. We don't have that widespread of an uptake of infection in the U.S. or in the UK. UK data also shows those kinds of numbers. They're reflected in a cohort that have had a natural infection and recovered from that, and then acquired the immune response associated with that.  It's seen in the numbers, for instance, in those cases where there is an accounting, such as in the Great Britain database, the British database, where they say the fraction of the population that's been vaccinated, and then the fraction of the population that's acquired natural immunity. It's also covered in the CDC slide deck that was leaked. I don't think that was available when we had our last conversation.  At the early outset, at the front edge of the Delta outbreak here in the United States, there was a key slide deck that was disclosed to the Washington Post without approval by a CDC employee. Within that slide deck, it showed a number of confidential internal assessments that weren't intended to be shared with the public. Those assessments also included an estimate that we had something like 50 per cent of the population that had accepted vaccine at that point in time. In addition, there was something like 20 per cent of the population that had been infected.  So if you add those two, if you were to consider natural infection as providing some degree of protection against the virus, then we would move from something like 50 per cent vaccine uptake to something like 70 per cent of the population at that point in time that had actually acquired some form of immunity either through vaccination or infection. So that's the basis of my seat-of-the-pants estimate.  In addition, in the CDC slide deck, the government revealed in two key slides that were at the center of that deck, that their epidemiologic calculations and projections were such that the reproductive coefficient of Delta was something in the range of eight. There's other papers that suggest it's more like a little over five, that it was as infectious as chickenpox approximately, which is highly infectious, about two to three times more infectious than the Alpha strain was.  Based on those projections and some assumptions about the percent of the population that had been naturally infected, and the percent of the population that had taken up vaccine, and some assumptions about the effectiveness of mask use in protecting either an individual from being infected by a third party that wasn't using masks or protecting a third party from infection from somebody that was using a mask and was infected—there were a series of projection curves about how that could impact on the spread of the virus.  Basically when you work through those curves, what they demonstrated was that even if we had 100 per cent vaccine uptake with these vaccines, where the technical term is leaky, that do not provide perfect protection against infection, that we would not be able to stop the spread of the virus through the U.S. population. We would slow it. So that's where those estimates come from.  That's where that assessment that is being used as the basis for advocating widespread mask deployment throughout the United States, that's where that policy comes from. It's a CDC analysis that if we don't use masks, then the virus will spread quite rapidly. If we do have full compliance with mask use, we can slow it down a bit. And so that's why we have these various mask mandates throughout the United States now. Mr. Jekielek: Fascinating. You started talking about natural immunity here. I thought it was some of the most interesting, robust data, at least to my eye. Again, you're the one who's going to be speaking on this. Dr. Malone: I agree, and a lot of people agree. It was covered in Science magazine. It's still a pre-print, but it was robust enough, and well enough constructed that even on the basis of the pre-print, Science magazine went ahead and made the clear point. Really, throughout the world, there was recognition that this new data coming out of Israel, as I recall, demonstrated that the term that's often used is natural immunity. It's an odd term, but it's now in common language.  What that means is protection afforded by having been infected and recovered from infection, which will generate a broad immune response. And it's now been shown in that paper and others that the breadth of that immune response in terms of memory T and B cell populations is more diverse and more long lasting than the breadth of immune response elicited by the spike based vaccines alone.  That data that you're alluding to showed that this natural immunity is broader and more durable, which contradicted some studies that the CDC had developed. So we were in a kind of tension. Which is the real data, the CDC data, or these other papers that are evaluated memory T and B cell populations? Which is true? We have multiple truths or multiple pieces of data, plus different groups claiming it's one way or the other.  Then this data was dropped about the evidence of protection. It seems to indicate and be consistent with the claims that the breadth and durability of the immune response was superior with the natural infection in recovery. There's also evidence that there's a significant, depending on the timeframe, six to twenty-fold improvement in protection from infection and disease associated with the natural immunity acquired from prior infection, compared to that conferred by the vaccine.  So now the public, in their social contract with the public health agencies, is faced with the situation where they had been told that natural immunity was not as protective, and that they can't rely on that. If you've been previously infected, you should still get both doses of vaccine, and this vaccination would provide broad, durable protection. It would protect you, and it would protect your elders from you potentially spreading disease to them.  Now, those things have all come into question. The population is still reeling from that. We have kind of dug into these camps. My sense is that people haven't really fully processed what this means. It is profound.  We were discussing before we started shooting, that I had a long podcast interview today and a kind of advisory session with a group of Latin American physicians and scientists that were evaluating public policy for vaccine rollout versus early treatment options for the different cohorts that they have to protect. They were seeing this data from the eyes of folks that really haven't had good access to vaccines, but are facing the prospects that their countries could execute vaccine contracts and bring in these vaccines. They are asking the question, “Does this make sense for us? Is this good policy? Should our country invest in these mRNA vaccines?”  That is why they were talking to me. “What are we going to get for it if we do this? What's going to be the benefit to our population?” It was a very level-headed discussion. But they were pushing me in this, getting back to this theme of me being the vaccine skeptic. They were the ones pushing me saying, “We just don't see the value here for our populations. We don't see a compelling case when these products aren't stopping the spread. They are going to have to be re-administered fairly frequently if they're to be effective?”  Now, the other thing that comes out of this, a concern that the World Health Organization hasn't really come to terms with—I'm speaking of the CDC and the WHO and the whole global infrastructure, including the Israeli government—is one of now mandating a third jab. So in Israel, if you haven't received all three, you're not considered fully vaccinated. Mr. Jekielek: You have a six month window, if I'm not mistaken. Dr. Malone: Precisely. But one of the things about the Israeli data is that they vaccinated in such a bolus, in such a short push, because they have such a compliant population, that essentially, they have a spike in vaccinated persons. So they're all moving concurrently through that six month window now.  There was a pivotal interview with the director of the CDC and she was asked, “Do we have any data? Do we have data, or do we just have hope about the benefits of the third dose?” And she, to her credit, acknowledged that we don't have data. All we have is hope.  Here's the problem with that. Vaccine responses are not linear. More is not better. There are many cases where if you dose more or dose more frequently or move beyond a prime and a boost, you can actually quench the immune response. You can move into “high zone tolerance.” You can move into a situation where your immune responses drop.  Now there's a little bit of foreshadowing on this in another paper that's out where they looked at the effects of vaccination post-infection. Remember this was the policy, that those like me that have been infected should go ahead and take two jabs, take two doses of vaccine. Mr. Jekielek: Which you did. Dr. Malone: Which I did, hoping that it would be helpful for a long COVID period. That data hasn't really played out that way. And there's a paper showing that you can actually quench T-cell responses. You get an improved kind of a super immune response, they assert in that manuscript, after a single dose when you've been previously infected. But with the second dose, your T-cell population actually gets quenched, which is consistent with high zone tolerance.  So if that paper was to be expanded and verified with more robust numbers, it would suggest that one dose after natural infection would be a good thing. Two doses would be a bad thing. Now that's the equivalent of three doses if you think about it, natural infection being dose one. So to say that we don't have any data is a little misleading. We have some leading indicators that suggest that it might not be such a good idea. And now, that data will come out from Israel. The conservative position to take is time will tell, and then we will know.  The Israelis continue to be in the throes of a very active Delta virus infection surge right now. There's some other very intriguing tidbits going on here in this whole public policy of vaccines versus no vaccines, versus universal vaccines, versus the Barrington position that we should selectively vaccinate those that are at high risk. Mr. Jekielek: The Great Barrington Declaration? Dr. Malone: Yes, the Great Barrington Declaration. After that whole matrix of decisions, in comes Sweden. You may recall that Sweden was roundly criticized for this naive notion that they weren't going to vaccinate. They were going to allow the virus to have its will with the population. They have backtracked from that now, to be technically accurate. They have about 40 per cent vaccine uptake and they've acknowledged that position was naive and counterproductive. They had excess deaths initially in the high-risk cohorts.  But what they did do was have a lot more natural infection with alpha and beta strains. And now that Delta is moving through the region, they have an extremely low mortality rate, often hitting zero on any one day—in comparison to some of their neighbors that didn't take that policy, and didn't have such widespread natural infection. Like Finland, for example, where they deployed vaccine very avidly and had good uptake, they're having the exponential growth rate curve that's happening in many other Northern European countries right now. Mr. Jekielek: I'm going to comment here. This is very interesting because you're interpreting this data a bit differently than Dr. Martin Kulldorff, who is from Sweden.  His commentary in a recent interview we did was simply that there were no mandates of any sort ever in Sweden, yet their vaccine use is actually quite high. He said it's one of the higher rates that exist. But he didn't factor in this time period that you said at the beginning, where there was this idea of letting the natural infections happen. And you're saying the reason their rates are zero mortality is because of that. Dr. Malone: Yes. It is a very reasonable explanation for what's happened there. It's a differentiator between them and some of their neighboring countries. They did have that early policy and they did have fairly widespread infection. So that would be consistent with the data suggesting that natural infection is providing broader and more durable immunity.  This gets to the logic of a selective deployment of vaccines to those that are at highest risk. For that fragment of the population, let's say below 65, depending on where you want to cut the line, 60, 65, 70, some people go down to 55, not providing vaccine coverage to those individuals unless they're in a very high risk population, morbidly obese, or with immunologic deficiencies—that may be a more enlightened public policy.  By the way, it is one more consistent with the WHO position that we still have limited vaccine supply, and it would be far more appropriate and equitable to deploy that vaccine supply more broadly globally to protect the elders in particular throughout the world, rather than this focus on universal vaccination.  Now with a booster, a third booster, a third dose, there's been multiple statements by the WHO that they believe this is not ethical. Now, I had another interview today with a journalist podcaster who is from South Africa but living in France, and very aware of the French resistance that's developing now to vaccines with all those protests. Mr. Jekielek: To vaccine mandates, correct? Dr. Malone: In particular, yes. His point was that if you look at this through the eyes of emerging economies, this Western focus on universal vaccination of their populations and now a third vaccine for their populations and their unwillingness to share the technology is a form of imperialism and hegemony. The Western nations have access to this technology and these doses and they're not willing to share it with the rest of the world.  So we've got a series of things here where this kind of imbalance in distribution of these vaccines as a resource is creating or exacerbating concerns that exist widely in economically disadvantaged countries. There's just not a level playing field and we're all in this boat together with this disease. Yet we're not being equitable in distribution of the countermeasures that are available. Mr. Jekielek: This is fascinating, even as others that you're speaking with are asking, “Do we even need these at this point?” That's fascinating. Dr. Malone: Yes, I agree. So what does this mean? I don't know. What I sense is, again, we're in one of those moments where there is chaos. There's lack of structure and consensus about how to move forward. And my sense is, getting back to the U.S. government, we're in a position now where a lot of the core assumptions underlying the vaccine strategy have been called into question. We don't really know what's on the other side.  Then on top of that, it's becoming increasingly apparent that these repurposed drugs and other agents that could provide protection and mitigate death and disease, if they were deployed early in outpatient environments, access to those that are being actively suppressed. That's another one of those, “This doesn't make sense,” kind of problems. It is causing a lot of questioning about the motivations of those that are guiding public policy right now. The second part of this episode will be released on Saturday, Sept. 4, at 7 p.m. ET. Below is a list of references mentioned or related to the discussion in this episode:  “Vaccinated and unvaccinated individuals have similar viral loads in communities with a high prevalence of the SARS-CoV-2 delta variant” (Note: This is a preprint). “Fauci: Amount of virus in breakthrough delta cases ‘almost identical' to unvaccinated” — The Hill CDC: “Outbreak of SARS-CoV-2 Infections, Including COVID-19 Vaccine Breakthrough Infections, Associated with Large Public Gatherings — Barnstable County, Massachusetts, July 2021” “Predominance of antibody-resistant SARS-CoV-2 variants in vaccine breakthrough cases from the San Francisco Bay Area, California” (Note: This is a preprint) “New delta variant studies show the pandemic is far from over” — ScienceNews “Read: Internal CDC document on breakthrough infections” — The Washington Post “New UCSF study: Vaccine-resistant viruses are driving ‘breakthrough' COVID infections” — The Mercury News “Comparing SARS-CoV-2 natural immunity to vaccine-induced immunity: reinfections versus breakthrough infections” (Note: This is a preprint) “Having SARS-CoV-2 once confers much greater immunity than a vaccine—but vaccination remains vital” — Science “Differential effects of the second SARS-CoV-2 mRNA vaccine dose on T cell immunity in naïve and COVID-19 recovered individuals” (Note: This is a preprint) “SARS-CoV-2 variants of concern and variants under investigation in England” — Public Health England “Safety of the BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting” — The New England Journal of Medicine “Real-World Study Captures Risk of Myocarditis With Pfizer Vax” — MedPage Today CDC: “Effectiveness of COVID-19 Vaccines in Preventing SARS-CoV-2 Infection Among Frontline Workers Before and During B.1.617.2 (Delta) Variant Predominance — Eight U.S. Locations, December 2020—August 2021” “CDC: Covid-19 Vaccine Effectiveness Fell From 91% To 66% With Delta Variant“ — Forbes “SARS-CoV-2 infection induces long-lived bone marrow plasma cells in humans” — Nature CDC: “Reduced Risk of Reinfection with SARS-CoV-2 After COVID-19 Vaccination — Kentucky, May-June 2021” “Causes and consequences of purifying selection on SARS-CoV-2” — Genome Biology and Evolution “The reproductive number of the Delta variant of SARS-CoV-2 is far higher compared to the ancestral SARS-CoV-2 virus” — Journal of Travel Medicine “Mutation rate of COVID-19 virus is at least 50 percent higher than previously thought” — Phys.org “Differential effects of the second SARS-CoV-2 mRNA vaccine dose on T cell immunity in naïve and COVID-19 recovered individuals” (Note: This is a preprint) Subscribe to the American Thought Leaders newsletter so you never miss an episode. You can also follow American Thought Leaders on Parler, Facebook, or YouTube. If you'd like to donate to support our work, you can do so here. Follow Epoch TV on Facebook and Twitter. 

American Conservative University
American Thought Leaders- PART 2: Dr. Robert Malone on Ivermectin, Escape Mutants, and the Faulty Logic of Vaccine Mandates. AMERICAN THOUGHT LEADERS

American Conservative University

Play Episode Listen Later Sep 11, 2021 42:59


American Thought Leaders- PART 2: Dr. Robert Malone on Ivermectin, Escape Mutants, and the Faulty Logic of Vaccine Mandates. AMERICAN THOUGHT LEADERS PART 2: Dr. Robert Malone on Ivermectin, Escape Mutants, and the Faulty Logic of Vaccine Mandates In part one of this American Thought Leaders episode, mRNA vaccine inventor Dr. Robert Malone explained the latest research on COVID-19 vaccines, booster shots, and natural immunity. Now in part two, we take a closer look at repurposed drugs like ivermectin and how a universal vaccination policy could actually backfire—and bring about the emergence of vaccine-resistant escape mutants. At their core, vaccine mandates are not just unethical and divisive, but also “impractical and unnecessary,” says Dr. Malone. You can watch the first part of this episode here. Below is a list of references mentioned or related to the discussion in this episode:  “Ivermectin for preventing and treating COVID-19” — The Cochrane Database of Systematic Reviews “Use of Ivermectin Is Associated With Lower Mortality in Hospitalized Patients With Coronavirus Disease 2019” — Chest Journal “Review of the Emerging Evidence Demonstrating the Efficacy of Ivermectin in the Prophylaxis and Treatment of COVID-19” — American Journal of Therapeutics “Effects of Ivermectin in Patients With COVID-19: A Multicenter, Double-Blind, Randomized, Controlled Clinical Trial” — Clinical Therapeutics “Dexamethasone in Hospitalized Patients with Covid-19” — The New England Journal of Medicine “ACTIV-6: COVID-19 Study of Repurposed Medications” — NIH “Convergent antibody responses to the SARS-CoV-2 spike protein in convalescent and vaccinated individuals” — Cell Reports “Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization” — Nature The SARS-CoV-2 Delta variant is poised to acquire complete resistance to wild-type spike vaccines (Note: This is a preprint) “Mutation rate of COVID-19 virus is at least 50 percent higher than previously thought” — Phys.org “Infection and Vaccine-Induced Neutralizing-Antibody Responses to the SARS-CoV-2 B.1.617 Variants” — The New England Journal of Medicine “Why is the ongoing mass vaccination experiment driving a rapid evolutionary response of SARS-CoV-2?” — Trial Site News “The emergence and ongoing convergent evolution of the N501Y lineages coincides with a major global shift in the SARS-CoV-2 selective landscape” (Note: This is a preprint) “The Lambda variant of SARS-CoV-2 has a better chance than the Delta variant to escape vaccines” (Note: This is a preprint) “Imperfect Vaccination Can Enhance the Transmission of Highly Virulent Pathogens” — PLOS Biology “Vaccinated and unvaccinated individuals have similar viral loads in communities with a high prevalence of the SARS-CoV-2 delta variant” (Note: This is a preprint). “Fauci: Amount of virus in breakthrough delta cases ‘almost identical' to unvaccinated” — The Hill CDC: “Outbreak of SARS-CoV-2 Infections, Including COVID-19 Vaccine Breakthrough Infections, Associated with Large Public Gatherings — Barnstable County, Massachusetts, July 2021” “Predominance of antibody-resistant SARS-CoV-2 variants in vaccine breakthrough cases from the San Francisco Bay Area, California” (Note: This is a preprint) “New delta variant studies show the pandemic is far from over” — ScienceNews “Read: Internal CDC document on breakthrough infections” — The Washington Post “New UCSF study: Vaccine-resistant viruses are driving ‘breakthrough' COVID infections” — The Mercury News “Comparing SARS-CoV-2 natural immunity to vaccine-induced immunity: reinfections versus breakthrough infections” (Note: This is a preprint) “Having SARS-CoV-2 once confers much greater immunity than a vaccine—but vaccination remains vital” — Science “Differential effects of the second SARS-CoV-2 mRNA vaccine dose on T cell immunity in naïve and COVID-19 recovered individuals” (Note: This is a preprint) “SARS-CoV-2 variants of concern and variants under investigation in England” — Public Health England “Safety of the BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting” — The New England Journal of Medicine “Real-World Study Captures Risk of Myocarditis With Pfizer Vax” — MedPage Today CDC: “Effectiveness of COVID-19 Vaccines in Preventing SARS-CoV-2 Infection Among Frontline Workers Before and During B.1.617.2 (Delta) Variant Predominance — Eight U.S. Locations, December 2020—August 2021” “CDC: Covid-19 Vaccine Effectiveness Fell From 91% To 66% With Delta Variant“ — Forbes “SARS-CoV-2 infection induces long-lived bone marrow plasma cells in humans” — Nature “Causes and consequences of purifying selection on SARS-CoV-2” — Genome Biology and Evolution “The reproductive number of the Delta variant of SARS-CoV-2 is far higher compared to the ancestral SARS-CoV-2 virus” — Journal of Travel Medicine Subscribe to the American Thought Leaders newsletter so you never miss an episode. You can also follow American Thought Leaders on Parler, Facebook, or YouTube. If you'd like to donate to support our work, you can do so here. Follow Epoch TV on Facebook and Twitter. 

Neurology Minute
Parasitic Infections of the Peripheral Nervous System - Part 2

Neurology Minute

Play Episode Listen Later Sep 9, 2021 2:17


Neurology Minute
Parasitic Infections of the Peripheral Nervous System - Part 1

Neurology Minute

Play Episode Listen Later Sep 8, 2021 2:45


5 Things
New COVID-19 infections up 316% from last Labor Day

5 Things

Play Episode Listen Later Sep 7, 2021 9:20


The pandemic is surging in both highly vaccinated and undervaccinated communities. Plus, Hurricane Larry keeps moving in the Atlantic, the U.S. is working with the Taliban to evacuate more people from Afghanistan, residents return to Lake Tahoe after evacuations and 'American Crime Story' tackles President Bill Clinton's affair.(Audio: Associated Press)See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.